Feasibility, Acceptability, and Preliminary Efficacy of a Novel Personalized Mobile Intervention for Suicide
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Butler Hospital
- Enrollment
- 10
- Locations
- 2
- Primary Endpoint
- Ecological Momentary Assessment (EMA) Adherence
Study Overview
Brief Summary
The primary aim of this grant is to conduct pilot testing on a novel personalized mobile intervention for suicide - Mobile Application to Prevent Suicide (MAPS) - and to establish feasibility, acceptability, safety, and primary outcomes (i.e., suicidal ideation and behavior; re-hospitalization).
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Intervention Model
- Single Group
- Primary Purpose
- Treatment
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to 26 Years (Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Suicidal ideation and/or suicidal behavior in the past month verified by the C-SSRS
- •Between the ages of 18 and 26
- •English proficiency
- •Comfortable with smartphone technology
- •Deemed by the treatment team to be stable enough to complete study procedures
Exclusion Criteria
- •Current psychotic or manic symptoms severe enough to interfere with study procedures
Outcomes
Primary Outcomes
Ecological Momentary Assessment (EMA) Adherence
Time Frame: 4 weeks
Number of assessments completed out of total.
Acceptability of Research Procedures
Time Frame: 1 month
Feedback on qualitative interview
Acceptability of MAPS Intervention
Time Frame: 1 month
Feedback on qualitative interview.
Acceptability of Research (Recruitment)
Time Frame: Baseline
Measured by recruitment rate.
Acceptability of Research (Dropout)
Time Frame: 1 month
Measured by dropout rate.
Patient Satisfaction
Time Frame: 1 month
Measured using the Client Satisfaction Questionnaire, a self-report measure of satisfaction with treatment. Scores range from 8 to 32, with higher scores representing higher satisfaction.
Satisfaction with MAPS Intervention
Time Frame: 4 weeks
Measured by protocol completion rate.
Secondary Outcomes
- Rehospitalization(1 month)
- Suicidal Ideation and Behavior(1 month)